比音勒芬(002832.SZ):終止併購江西微傳的意向協議
格隆匯 9 月 3日丨比音勒芬(002832.SZ)公佈,公司於2020年7月17日與江西微傳網絡科技有限公司(“江西微傳”)、上海微祥網絡科技有限公司(“目標公司”)簽訂了《併購意向協議》,公司擬收購江西微傳所持有的目標公司100%股權。
自意向協議簽署後,公司組織工作團隊對目標公司開展了盡職調查,並得到了目標公司的積極配合,雙方經過多次溝通論證,認為在合作方式、合作範圍等方面仍需作更進一步的探討研究,故一致同意終止《併購意向協議》。雙方協商將在多米粒電商平台、短視頻方面開展業務合作,持續強化公司新零售業務的發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.